Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Deep Brain Stimulation | Research

Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson’s disease

Authors: Feng Zhang, Feng Wang, Cong-Hui Li, Ji-Wei Wang, Chun-Lei Han, Shi-Ying Fan, Dong-Mei Gao, Yu-Jing Xing, Chen Yang, Jian-Guo Zhang, Fan-Gang Meng

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

To study the effects of subthalamic nucleus-deep brain stimulation (STN-DBS) on autonomic dysfunctions in Parkinson’s disease (PD) patients.

Methods

A total of 57 PD patients who underwent bilateral STN-DBS from March to December 2018, were retrospectively analyzed. Preplanned assessments at baseline and postoperatively at 1, 3, and 6 months also included the Scales for Outcomes in Parkinson’s Disease-Autonomic questionnaire (SCOPA-Aut), the Unified Parkinson’s Disease Rating Scale (UPDRS) III score, levodopa equivalent day dose (LEDD), Parkinson’s Disease Quality of Life Scale (PDQ-39), the Hamilton Anxiety Rating Scale (HAMA), and the Hamilton Depression Rating Scale (HAMD).

Results

The SCOPA-Aut scores improved significantly [14.59% (18.32%), 24.00% (27.05%), 22.16% (27.07%), all P < 0.001] at 1 month, 3 months, and 6 months of STN-DBS, respectively. Analysis of the SCOPA-Aut sub-items showed significant improvements only in urine and thermoregulation sub-items at 6 months after surgery (P < 0.001). There was no significant correlation between improvements of SCOPA-Aut scores and improvements of PDQ-39 scores (P > 0.05) at 6 months after surgery. SCOPA-Aut scores were positively correlated with age (r = 0.428, P = 0.001); the improvements of SCCOPA-Aut scores were positively correlated with improvements of HAMA and HAMD scores (HAMA: r = 0.325, P = 0.015; HAMD: r = 0.265, P = 0.049) at 6 months after surgery.

Conclusion

STN-DBS improved autonomic dysfunction symptoms of PD patients, and urinary and thermoregulatory sub-items of autonomic dysfunction were improved in the short-term after surgery. There was a close relationship between improved autonomic symptoms and improved anxiety and depression 6 months after surgery. We should therefore direct more attention to autonomic dysfunctions in PD involving detailed preoperative evaluations and postoperative follow-ups, to improve the quality of life of patients.
Literature
4.
go back to reference Pietraszko W, Furgala A, Gorecka-Mazur A, et al. Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with Parkinson’s disease. Folia Med Cracov. 2013;53(2):15–22.PubMed Pietraszko W, Furgala A, Gorecka-Mazur A, et al. Efficacy of deep brain stimulation of the subthalamic nucleus on autonomic dysfunction in patients with Parkinson’s disease. Folia Med Cracov. 2013;53(2):15–22.PubMed
19.
go back to reference Wang XH, Zhang L, Wang SJ, et al. Effects of deep brain stimulation on non-motor symptoms of Parkinson’s disease. J Clin Neurol. 2018;31(2):147–50. Wang XH, Zhang L, Wang SJ, et al. Effects of deep brain stimulation on non-motor symptoms of Parkinson’s disease. J Clin Neurol. 2018;31(2):147–50.
Metadata
Title
Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson’s disease
Authors
Feng Zhang
Feng Wang
Cong-Hui Li
Ji-Wei Wang
Chun-Lei Han
Shi-Ying Fan
Dong-Mei Gao
Yu-Jing Xing
Chen Yang
Jian-Guo Zhang
Fan-Gang Meng
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02651-z

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue